Trial Outcomes & Findings for Dulce Digital-Me: An Adaptive mHealth Intervention for Underserved Hispanics With Diabetes (NCT NCT03130699)

NCT ID: NCT03130699

Last Updated: 2025-06-25

Results Overview

Glycosylated Hemoglobin (HbA1c) six months after enrollment

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

310 participants

Primary outcome timeframe

6 months from baseline

Results posted on

2025-06-25

Participant Flow

Between October 2017 and March 2020, the study enrolled 310 Hispanic adults with low income and poorly managed type 2 diabetes from a San Diego County Federally Qualified Health Center.

The target sample size based on power analysis was N=414. Enrollment started October 31, 2017 was paused on March 13, 2020, and then concluded early due to the COVID-19 pandemic. Because the design accommodated at 30% attrition rate, sample size was adequate for analysis of outcomes.

Participant milestones

Participant milestones
Measure
Dulce Digital
The first of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives one-size-fits-all educational text messages, with patient monitoring and transmission of blood glucose values. Dulce Digital: One-size-fits-all educational text messages, with patient monitoring and transmission of blood glucose values.
Dulce Digital-Me (Automated Delivery)
The second of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered via automated algorithm-driven messaging, incorporated into existing primary care team processes. Dulce Digital-Me (Automated Delivery): Educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered via automated algorithm-driven messaging, incorporated into existing primary care team processes.
Dulce Digital-Me (Medical Assistant)
The third of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered by Medical Assistants, incorporated into existing primary care team processes. Dulce Digital-Me (Medical Assistant): Educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered by Medical Assistants, incorporated into existing primary care team processes.
Overall Study
STARTED
107
106
97
Overall Study
COMPLETED
67
66
65
Overall Study
NOT COMPLETED
40
40
32

Reasons for withdrawal

Reasons for withdrawal
Measure
Dulce Digital
The first of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives one-size-fits-all educational text messages, with patient monitoring and transmission of blood glucose values. Dulce Digital: One-size-fits-all educational text messages, with patient monitoring and transmission of blood glucose values.
Dulce Digital-Me (Automated Delivery)
The second of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered via automated algorithm-driven messaging, incorporated into existing primary care team processes. Dulce Digital-Me (Automated Delivery): Educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered via automated algorithm-driven messaging, incorporated into existing primary care team processes.
Dulce Digital-Me (Medical Assistant)
The third of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered by Medical Assistants, incorporated into existing primary care team processes. Dulce Digital-Me (Medical Assistant): Educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered by Medical Assistants, incorporated into existing primary care team processes.
Overall Study
Lost to Follow-up
34
37
26
Overall Study
Withdrawal by Subject
5
1
0
Overall Study
Withdrawal by PI
1
2
5
Overall Study
Death
0
0
1

Baseline Characteristics

Sample sizes differ due to missing values.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Dulce Digital
n=107 Participants
The first of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives one-size-fits-all educational text messages, with patient monitoring and transmission of blood glucose values. Dulce Digital: One-size-fits-all educational text messages, with patient monitoring and transmission of blood glucose values.
Dulce Digital-Me (Automated Delivery)
n=106 Participants
The second of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered via automated algorithm-driven messaging, incorporated into existing primary care team processes. Dulce Digital-Me (Automated Delivery): Educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered via automated algorithm-driven messaging, incorporated into existing primary care team processes.
Dulce Digital-Me (Medical Assistant)
n=97 Participants
The third of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered by Medical Assistants, incorporated into existing primary care team processes. Dulce Digital-Me (Medical Assistant): Educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered by Medical Assistants, incorporated into existing primary care team processes.
Total
n=310 Participants
Total of all reporting groups
Age, Continuous
51.22 years
STANDARD_DEVIATION 10.7 • n=107 Participants
53.21 years
STANDARD_DEVIATION 10.26 • n=106 Participants
51.90 years
STANDARD_DEVIATION 9.49 • n=97 Participants
52.11 years
STANDARD_DEVIATION 10.18 • n=310 Participants
Sex: Female, Male
Female
76 Participants
n=107 Participants
73 Participants
n=106 Participants
67 Participants
n=97 Participants
216 Participants
n=310 Participants
Sex: Female, Male
Male
31 Participants
n=107 Participants
33 Participants
n=106 Participants
30 Participants
n=97 Participants
94 Participants
n=310 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
107 Participants
n=107 Participants
106 Participants
n=106 Participants
97 Participants
n=97 Participants
310 Participants
n=310 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
0 Participants
n=107 Participants
0 Participants
n=106 Participants
0 Participants
n=97 Participants
0 Participants
n=310 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=107 Participants
0 Participants
n=106 Participants
0 Participants
n=97 Participants
0 Participants
n=310 Participants
Race (NIH/OMB)
American Indian or Alaska Native
3 Participants
n=107 Participants
1 Participants
n=106 Participants
0 Participants
n=97 Participants
4 Participants
n=310 Participants
Race (NIH/OMB)
Asian
1 Participants
n=107 Participants
0 Participants
n=106 Participants
0 Participants
n=97 Participants
1 Participants
n=310 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants
n=107 Participants
1 Participants
n=106 Participants
1 Participants
n=97 Participants
3 Participants
n=310 Participants
Race (NIH/OMB)
Black or African American
2 Participants
n=107 Participants
1 Participants
n=106 Participants
0 Participants
n=97 Participants
3 Participants
n=310 Participants
Race (NIH/OMB)
White
42 Participants
n=107 Participants
37 Participants
n=106 Participants
27 Participants
n=97 Participants
106 Participants
n=310 Participants
Race (NIH/OMB)
More than one race
2 Participants
n=107 Participants
2 Participants
n=106 Participants
1 Participants
n=97 Participants
5 Participants
n=310 Participants
Race (NIH/OMB)
Unknown or Not Reported
56 Participants
n=107 Participants
64 Participants
n=106 Participants
68 Participants
n=97 Participants
188 Participants
n=310 Participants
Region of Enrollment
United States
107 participants
n=107 Participants
106 participants
n=106 Participants
97 participants
n=97 Participants
310 participants
n=310 Participants
Less than High School Education/GED
81 Participants
n=107 Participants
73 Participants
n=106 Participants
76 Participants
n=97 Participants
230 Participants
n=310 Participants
Yearly household income
Less than $20,000
64 Participants
n=107 Participants
62 Participants
n=106 Participants
63 Participants
n=97 Participants
189 Participants
n=310 Participants
Yearly household income
$20,000 to $30,000
14 Participants
n=107 Participants
19 Participants
n=106 Participants
16 Participants
n=97 Participants
49 Participants
n=310 Participants
Yearly household income
Greater than $30,000
23 Participants
n=107 Participants
13 Participants
n=106 Participants
10 Participants
n=97 Participants
46 Participants
n=310 Participants
Yearly household income
Unknown or Not Reported
6 Participants
n=107 Participants
12 Participants
n=106 Participants
8 Participants
n=97 Participants
26 Participants
n=310 Participants
Employment
Not Employed
55 Participants
n=107 Participants
68 Participants
n=106 Participants
45 Participants
n=97 Participants
168 Participants
n=310 Participants
Employment
Employed Part Time
21 Participants
n=107 Participants
19 Participants
n=106 Participants
32 Participants
n=97 Participants
72 Participants
n=310 Participants
Employment
Employed Full Time
30 Participants
n=107 Participants
19 Participants
n=106 Participants
20 Participants
n=97 Participants
69 Participants
n=310 Participants
Employment
Unknown or Not Reported
1 Participants
n=107 Participants
0 Participants
n=106 Participants
0 Participants
n=97 Participants
1 Participants
n=310 Participants
Married or Living with Partner
74 Participants
n=107 Participants
65 Participants
n=106 Participants
64 Participants
n=97 Participants
203 Participants
n=310 Participants
Place of Birth
US 50 States/District of Columbia
5 Participants
n=107 Participants
9 Participants
n=106 Participants
6 Participants
n=97 Participants
20 Participants
n=310 Participants
Place of Birth
Mexico
97 Participants
n=107 Participants
95 Participants
n=106 Participants
89 Participants
n=97 Participants
281 Participants
n=310 Participants
Place of Birth
Other
5 Participants
n=107 Participants
2 Participants
n=106 Participants
2 Participants
n=97 Participants
9 Participants
n=310 Participants
Primary Language is Spanish
101 Participants
n=107 Participants
98 Participants
n=106 Participants
90 Participants
n=97 Participants
289 Participants
n=310 Participants
Has Some Type of Health Insurance
53 Participants
n=107 Participants
57 Participants
n=106 Participants
42 Participants
n=97 Participants
152 Participants
n=310 Participants
Health Literacy
Adequate
56 Participants
n=107 Participants
56 Participants
n=106 Participants
55 Participants
n=97 Participants
167 Participants
n=310 Participants
Health Literacy
Limited
51 Participants
n=107 Participants
50 Participants
n=106 Participants
42 Participants
n=97 Participants
143 Participants
n=310 Participants
Duration of Diabetes Diagnosis
10.22 years
STANDARD_DEVIATION 8.22 • n=107 Participants
10.31 years
STANDARD_DEVIATION 8.25 • n=106 Participants
10.59 years
STANDARD_DEVIATION 8.26 • n=97 Participants
10.37 years
STANDARD_DEVIATION 8.22 • n=310 Participants
BMI
31.84 units kg/m^2
STANDARD_DEVIATION 5.82 • n=107 Participants
33.51 units kg/m^2
STANDARD_DEVIATION 7.35 • n=106 Participants
31.37 units kg/m^2
STANDARD_DEVIATION 6.34 • n=97 Participants
32.22 units kg/m^2
STANDARD_DEVIATION 6.54 • n=310 Participants
Glycosylated Hemoglobin (HbA1c)
9.25 percentage of Glycosylated Hemoglobin
STANDARD_DEVIATION 1.64 • n=107 Participants
9.31 percentage of Glycosylated Hemoglobin
STANDARD_DEVIATION 1.58 • n=106 Participants
9.37 percentage of Glycosylated Hemoglobin
STANDARD_DEVIATION 1.56 • n=97 Participants
9.31 percentage of Glycosylated Hemoglobin
STANDARD_DEVIATION 1.59 • n=310 Participants
Low-density Lipoprotein-cholesterol (LDL-C);
93.07 mg/dL
STANDARD_DEVIATION 38.75 • n=102 Participants • Sample sizes differ due to missing values.
91.17 mg/dL
STANDARD_DEVIATION 33.88 • n=102 Participants • Sample sizes differ due to missing values.
100.32 mg/dL
STANDARD_DEVIATION 41.03 • n=95 Participants • Sample sizes differ due to missing values.
94.72 mg/dL
STANDARD_DEVIATION 38.00 • n=299 Participants • Sample sizes differ due to missing values.
Systolic Blood Pressure (SBP)
121.36 mm/Hg
STANDARD_DEVIATION 17.11 • n=106 Participants • Sample sizes differ due to missing values.
122.69 mm/Hg
STANDARD_DEVIATION 17.96 • n=104 Participants • Sample sizes differ due to missing values.
123.08 mm/Hg
STANDARD_DEVIATION 20.10 • n=95 Participants • Sample sizes differ due to missing values.
122.35 mm/Hg
STANDARD_DEVIATION 18.33 • n=305 Participants • Sample sizes differ due to missing values.
Patient-Provider Communication
4.06 units on a scale
STANDARD_DEVIATION 1.03 • n=104 Participants • Sample sizes differ due to missing values.
3.97 units on a scale
STANDARD_DEVIATION 1.05 • n=102 Participants • Sample sizes differ due to missing values.
4.12 units on a scale
STANDARD_DEVIATION 1.02 • n=95 Participants • Sample sizes differ due to missing values.
4.05 units on a scale
STANDARD_DEVIATION 1.03 • n=301 Participants • Sample sizes differ due to missing values.
Patient Blood Glucose Monitoring
4.11 days per week
STANDARD_DEVIATION 1.26 • n=102 Participants • Sample sizes differ due to missing values.
4.46 days per week
STANDARD_DEVIATION 2.50 • n=95 Participants • Sample sizes differ due to missing values.
4.38 days per week
STANDARD_DEVIATION 2.83 • n=84 Participants • Sample sizes differ due to missing values.
4.31 days per week
STANDARD_DEVIATION 2.62 • n=281 Participants • Sample sizes differ due to missing values.
Participated in Aerobic Exercise
5.01 units on a scale
STANDARD_DEVIATION 1.64 • n=104 Participants • Sample sizes differ due to missing values.
5.14 units on a scale
STANDARD_DEVIATION 1.78 • n=98 Participants • Sample sizes differ due to missing values.
4.73 units on a scale
STANDARD_DEVIATION 1.67 • n=88 Participants • Sample sizes differ due to missing values.
4.97 units on a scale
STANDARD_DEVIATION 1.70 • n=290 Participants • Sample sizes differ due to missing values.
Participated in Strength Exercise
25 Participants
n=107 Participants
27 Participants
n=106 Participants
17 Participants
n=97 Participants
69 Participants
n=310 Participants
Participated in Flexibility Exercise
40 Participants
n=107 Participants
54 Participants
n=106 Participants
46 Participants
n=97 Participants
140 Participants
n=310 Participants
Healthy Eating Behaviors
49.63 units on a scale
STANDARD_DEVIATION 6.87 • n=107 Participants
50.29 units on a scale
STANDARD_DEVIATION 7.23 • n=106 Participants
49.33 units on a scale
STANDARD_DEVIATION 6.88 • n=97 Participants
49.76 units on a scale
STANDARD_DEVIATION 6.99 • n=310 Participants
Diabetes Distress
2.39 units on a scale
STANDARD_DEVIATION 1.01 • n=105 Participants • Sample sizes differ due to missing values.
2.43 units on a scale
STANDARD_DEVIATION 0.99 • n=101 Participants • Sample sizes differ due to missing values.
2.40 units on a scale
STANDARD_DEVIATION 0.97 • n=95 Participants • Sample sizes differ due to missing values.
2.41 units on a scale
STANDARD_DEVIATION 0.99 • n=301 Participants • Sample sizes differ due to missing values.
Adherence to Refills and Medications Scale (ARMS)
17.87 units on a scale
STANDARD_DEVIATION 3.99 • n=104 Participants • Sample sizes differ due to missing values.
18.28 units on a scale
STANDARD_DEVIATION 5.60 • n=99 Participants • Sample sizes differ due to missing values.
18.40 units on a scale
STANDARD_DEVIATION 4.40 • n=94 Participants • Sample sizes differ due to missing values.
18.18 units on a scale
STANDARD_DEVIATION 4.70 • n=297 Participants • Sample sizes differ due to missing values.

PRIMARY outcome

Timeframe: 6 months from baseline

Population: Participants that came in for 6-month measures

Glycosylated Hemoglobin (HbA1c) six months after enrollment

Outcome measures

Outcome measures
Measure
Dulce Digital
n=77 Participants
The first of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives one-size-fits-all educational text messages, with patient monitoring and transmission of blood glucose values.
Dulce Digital-Me (Automated Delivery)
n=76 Participants
The second of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered via automated algorithm-driven messaging, incorporated into existing primary care team processes.
Dulce Digital-Me (Medical Assistants)
n=73 Participants
The third of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered by Medical Assistants, incorporated into existing primary care team processes.
Dulce Digital-Me (Combined: Automated Delivery and Medical Assistants)
n=149 Participants
Dulce Digital-Me (Combination of two intervention groups: Automated Delivery and Medical Assistants)
Glycosylated Hemoglobin (HbA1c) 6 Months After Enrollment
8.17 percentage
Standard Deviation 1.51
7.99 percentage
Standard Deviation 1.61
8.44 percentage
Standard Deviation 1.48
8.21 percentage
Standard Deviation 1.56

PRIMARY outcome

Timeframe: 12 months from baseline

Population: Participants that came in for 12-month measures

Glycosylated Hemoglobin (HbA1c) twelve months after enrollment

Outcome measures

Outcome measures
Measure
Dulce Digital
n=67 Participants
The first of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives one-size-fits-all educational text messages, with patient monitoring and transmission of blood glucose values.
Dulce Digital-Me (Automated Delivery)
n=66 Participants
The second of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered via automated algorithm-driven messaging, incorporated into existing primary care team processes.
Dulce Digital-Me (Medical Assistants)
n=65 Participants
The third of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered by Medical Assistants, incorporated into existing primary care team processes.
Dulce Digital-Me (Combined: Automated Delivery and Medical Assistants)
n=131 Participants
Dulce Digital-Me (Combination of two intervention groups: Automated Delivery and Medical Assistants)
Glycosylated Hemoglobin (HbA1c) 12 Months After Enrollment
8.29 percentage
Standard Deviation 1.62
8.41 percentage
Standard Deviation 1.70
8.83 percentage
Standard Deviation 1.83
8.62 percentage
Standard Deviation 1.77

PRIMARY outcome

Timeframe: 6 months from baseline

Population: Participants

Low-density lipoprotein-cholesterol (LDL-C); six months after enrollment

Outcome measures

Outcome measures
Measure
Dulce Digital
n=60 Participants
The first of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives one-size-fits-all educational text messages, with patient monitoring and transmission of blood glucose values.
Dulce Digital-Me (Automated Delivery)
n=56 Participants
The second of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered via automated algorithm-driven messaging, incorporated into existing primary care team processes.
Dulce Digital-Me (Medical Assistants)
n=58 Participants
The third of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered by Medical Assistants, incorporated into existing primary care team processes.
Dulce Digital-Me (Combined: Automated Delivery and Medical Assistants)
n=174 Participants
Dulce Digital-Me (Combination of two intervention groups: Automated Delivery and Medical Assistants)
Low-density Lipoprotein-cholesterol (LDL-C); 6 Months After Enrollment
90.27 mg/dL
Standard Deviation 33.66
88.20 mg/dL
Standard Deviation 36.38
102.93 mg/dL
Standard Deviation 47.96
95.69 mg/dL
Standard Deviation 43.12

PRIMARY outcome

Timeframe: 12 months from baseline

Population: Participants

Low-density lipoprotein-cholesterol (LDL-C); twelve months after enrollment

Outcome measures

Outcome measures
Measure
Dulce Digital
n=41 Participants
The first of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives one-size-fits-all educational text messages, with patient monitoring and transmission of blood glucose values.
Dulce Digital-Me (Automated Delivery)
n=49 Participants
The second of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered via automated algorithm-driven messaging, incorporated into existing primary care team processes.
Dulce Digital-Me (Medical Assistants)
n=48 Participants
The third of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered by Medical Assistants, incorporated into existing primary care team processes.
Dulce Digital-Me (Combined: Automated Delivery and Medical Assistants)
n=138 Participants
Dulce Digital-Me (Combination of two intervention groups: Automated Delivery and Medical Assistants)
Low-density Lipoprotein-cholesterol (LDL-C); 12 Months After Enrollment
97.85 mg/dL
Standard Deviation 27.74
94.10 mg/dL
Standard Deviation 35.18
92.04 mg/dL
Standard Deviation 43.23
93.08 mg/dL
Standard Deviation 39.18

PRIMARY outcome

Timeframe: 6 months from baseline

Population: Participants

Systolic blood pressure (SBP); six months from enrollment

Outcome measures

Outcome measures
Measure
Dulce Digital
n=79 Participants
The first of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives one-size-fits-all educational text messages, with patient monitoring and transmission of blood glucose values.
Dulce Digital-Me (Automated Delivery)
n=73 Participants
The second of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered via automated algorithm-driven messaging, incorporated into existing primary care team processes.
Dulce Digital-Me (Medical Assistants)
n=72 Participants
The third of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered by Medical Assistants, incorporated into existing primary care team processes.
Dulce Digital-Me (Combined: Automated Delivery and Medical Assistants)
n=154 Participants
Dulce Digital-Me (Combination of two intervention groups: Automated Delivery and Medical Assistants)
Systolic Blood Pressure (SBP); 6 Months From Enrollment
126.70 mm/Hg
Standard Deviation 19.52
124.84 mm/Hg
Standard Deviation 18.66
124.78 mm/Hg
Standard Deviation 19.13
124.81 mm/Hg
Standard Deviation 18.83

PRIMARY outcome

Timeframe: 12 months from baseline

Population: Participants

Systolic blood pressure (SBP); twelve months from enrollment

Outcome measures

Outcome measures
Measure
Dulce Digital
n=64 Participants
The first of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives one-size-fits-all educational text messages, with patient monitoring and transmission of blood glucose values.
Dulce Digital-Me (Automated Delivery)
n=67 Participants
The second of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered via automated algorithm-driven messaging, incorporated into existing primary care team processes.
Dulce Digital-Me (Medical Assistants)
n=67 Participants
The third of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered by Medical Assistants, incorporated into existing primary care team processes.
Dulce Digital-Me (Combined: Automated Delivery and Medical Assistants)
n=134 Participants
Dulce Digital-Me (Combination of two intervention groups: Automated Delivery and Medical Assistants)
Systolic Blood Pressure (SBP); 12 Months From Enrollment
125.10 mm/Hg
Standard Deviation 17.38
122.82 mm/Hg
Standard Deviation 15.29
124.13 mm/Hg
Standard Deviation 19.54
123.47 mm/Hg
Standard Deviation 17.49

SECONDARY outcome

Timeframe: 6 months from baseline

Population: Participants

Patient-Provider Communication as reported by patient; six months from enrollment The minimum value on the scale is 1 and the maximum value on the scale is 5. A higher score is a better outcome.

Outcome measures

Outcome measures
Measure
Dulce Digital
n=70 Participants
The first of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives one-size-fits-all educational text messages, with patient monitoring and transmission of blood glucose values.
Dulce Digital-Me (Automated Delivery)
n=64 Participants
The second of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered via automated algorithm-driven messaging, incorporated into existing primary care team processes.
Dulce Digital-Me (Medical Assistants)
n=62 Participants
The third of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered by Medical Assistants, incorporated into existing primary care team processes.
Dulce Digital-Me (Combined: Automated Delivery and Medical Assistants)
n=126 Participants
Dulce Digital-Me (Combination of two intervention groups: Automated Delivery and Medical Assistants)
Patient-Provider Communication; 6 Months From Enrollment
4.18 score on a scale
Standard Deviation 1.05
4.04 score on a scale
Standard Deviation 1.02
4.28 score on a scale
Standard Deviation 0.80
4.16 score on a scale
Standard Deviation 0.92

SECONDARY outcome

Timeframe: 12 months from baseline

Population: Participants

Patient-Provider Communication as reported by patient; twelve months from enrollment The minimum value on the scale is 1 and the maximum value on the scale is 5. A higher score is a better outcome.

Outcome measures

Outcome measures
Measure
Dulce Digital
n=54 Participants
The first of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives one-size-fits-all educational text messages, with patient monitoring and transmission of blood glucose values.
Dulce Digital-Me (Automated Delivery)
n=60 Participants
The second of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered via automated algorithm-driven messaging, incorporated into existing primary care team processes.
Dulce Digital-Me (Medical Assistants)
n=48 Participants
The third of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered by Medical Assistants, incorporated into existing primary care team processes.
Dulce Digital-Me (Combined: Automated Delivery and Medical Assistants)
n=108 Participants
Dulce Digital-Me (Combination of two intervention groups: Automated Delivery and Medical Assistants)
Patient-Provider Communication; 12 Months From Enrollment
4.09 score on a scale
Standard Deviation 1.03
3.99 score on a scale
Standard Deviation 1.04
4.16 score on a scale
Standard Deviation 0.96
4.06 score on a scale
Standard Deviation 1.00

SECONDARY outcome

Timeframe: 6 months from baseline

Population: Participants

Patient Blood Glucose Monitoring as reported by patient; six months from enrollment The minimum value on this scale is 1 day per week and the maximum value on this scale is 7 days per week. A higher value on this scale is a better outcome.

Outcome measures

Outcome measures
Measure
Dulce Digital
n=69 Participants
The first of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives one-size-fits-all educational text messages, with patient monitoring and transmission of blood glucose values.
Dulce Digital-Me (Automated Delivery)
n=63 Participants
The second of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered via automated algorithm-driven messaging, incorporated into existing primary care team processes.
Dulce Digital-Me (Medical Assistants)
n=61 Participants
The third of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered by Medical Assistants, incorporated into existing primary care team processes.
Dulce Digital-Me (Combined: Automated Delivery and Medical Assistants)
n=124 Participants
Dulce Digital-Me (Combination of two intervention groups: Automated Delivery and Medical Assistants)
Patient Blood Glucose Monitoring; 6 Months From Enrollment
5.07 days per week
Standard Deviation 2.29
5.62 days per week
Standard Deviation 1.99
5.11 days per week
Standard Deviation 2.41
5.37 days per week
Standard Deviation 2.21

SECONDARY outcome

Timeframe: 12 months from baseline

Population: Participants

Patient Blood Glucose Monitoring as reported by patient; twelve months from enrollment The minimum value on this scale is 1 day per week and the maximum value on this scale is 7 days per week. A higher value on this scale is a better outcome.

Outcome measures

Outcome measures
Measure
Dulce Digital
n=52 Participants
The first of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives one-size-fits-all educational text messages, with patient monitoring and transmission of blood glucose values.
Dulce Digital-Me (Automated Delivery)
n=60 Participants
The second of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered via automated algorithm-driven messaging, incorporated into existing primary care team processes.
Dulce Digital-Me (Medical Assistants)
n=48 Participants
The third of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered by Medical Assistants, incorporated into existing primary care team processes.
Dulce Digital-Me (Combined: Automated Delivery and Medical Assistants)
n=108 Participants
Dulce Digital-Me (Combination of two intervention groups: Automated Delivery and Medical Assistants)
Patient Blood Glucose Monitoring; 12 Months From Enrollment
5.08 days per week
Standard Deviation 2.19
4.77 days per week
Standard Deviation 2.65
5.15 days per week
Standard Deviation 2.41
4.94 days per week
Standard Deviation 2.54

SECONDARY outcome

Timeframe: 6 months from baseline

Participated in Aerobic Exercise as reported by patient, six months from enrollment The minimum score is 1 and the maximum score is 7. A higher score is a better outcome.

Outcome measures

Outcome measures
Measure
Dulce Digital
n=68 Participants
The first of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives one-size-fits-all educational text messages, with patient monitoring and transmission of blood glucose values.
Dulce Digital-Me (Automated Delivery)
n=63 Participants
The second of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered via automated algorithm-driven messaging, incorporated into existing primary care team processes.
Dulce Digital-Me (Medical Assistants)
n=61 Participants
The third of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered by Medical Assistants, incorporated into existing primary care team processes.
Dulce Digital-Me (Combined: Automated Delivery and Medical Assistants)
n=124 Participants
Dulce Digital-Me (Combination of two intervention groups: Automated Delivery and Medical Assistants)
Participated in Aerobic Exercise; 6 Months From Enrollment
5.46 score on a scale
Standard Deviation 1.48
5.29 score on a scale
Standard Deviation 1.50
5.49 score on a scale
Standard Deviation 1.45
5.41 score on a scale
Standard Deviation 1.47

SECONDARY outcome

Timeframe: 12 months from baseline

Population: Participants

Participated in Aerobic Exercise as reported by patient, twelve months from enrollment The minimum score is 1 and the maximum score is 7. A higher score is a better outcome.

Outcome measures

Outcome measures
Measure
Dulce Digital
n=54 Participants
The first of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives one-size-fits-all educational text messages, with patient monitoring and transmission of blood glucose values.
Dulce Digital-Me (Automated Delivery)
n=57 Participants
The second of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered via automated algorithm-driven messaging, incorporated into existing primary care team processes.
Dulce Digital-Me (Medical Assistants)
n=47 Participants
The third of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered by Medical Assistants, incorporated into existing primary care team processes.
Dulce Digital-Me (Combined: Automated Delivery and Medical Assistants)
n=104 Participants
Dulce Digital-Me (Combination of two intervention groups: Automated Delivery and Medical Assistants)
Participated in Aerobic Exercise; 12 Months From Enrollment
5.11 score on a scale
Standard Deviation 1.48
5.12 score on a scale
Standard Deviation 1.77
4.72 score on a scale
Standard Deviation 1.94
4.94 score on a scale
Standard Deviation 1.85

SECONDARY outcome

Timeframe: 6 months from baseline

Population: Participants

Participated in Strength Exercise as reported by patient; six months from enrollment

Outcome measures

Outcome measures
Measure
Dulce Digital
n=89 Participants
The first of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives one-size-fits-all educational text messages, with patient monitoring and transmission of blood glucose values.
Dulce Digital-Me (Automated Delivery)
n=85 Participants
The second of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered via automated algorithm-driven messaging, incorporated into existing primary care team processes.
Dulce Digital-Me (Medical Assistants)
n=74 Participants
The third of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered by Medical Assistants, incorporated into existing primary care team processes.
Dulce Digital-Me (Combined: Automated Delivery and Medical Assistants)
n=159 Participants
Dulce Digital-Me (Combination of two intervention groups: Automated Delivery and Medical Assistants)
Participated in Strength Exercise; 6 Months From Enrollment
20 Participants
11 Participants
10 Participants
21 Participants

SECONDARY outcome

Timeframe: 12 months from baseline

Population: Participants

Participated in Strength Exercise as reported by patient; twelve months from enrollment

Outcome measures

Outcome measures
Measure
Dulce Digital
n=56 Participants
The first of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives one-size-fits-all educational text messages, with patient monitoring and transmission of blood glucose values.
Dulce Digital-Me (Automated Delivery)
n=63 Participants
The second of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered via automated algorithm-driven messaging, incorporated into existing primary care team processes.
Dulce Digital-Me (Medical Assistants)
n=51 Participants
The third of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered by Medical Assistants, incorporated into existing primary care team processes.
Dulce Digital-Me (Combined: Automated Delivery and Medical Assistants)
n=114 Participants
Dulce Digital-Me (Combination of two intervention groups: Automated Delivery and Medical Assistants)
Participated in Strength Exercise; 12 Months From Enrollment
12 Participants
9 Participants
8 Participants
17 Participants

SECONDARY outcome

Timeframe: 6 months from baseline

Population: Participants

Participated in Flexibility Exercise as reported by patient; six months from enrollment

Outcome measures

Outcome measures
Measure
Dulce Digital
n=89 Participants
The first of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives one-size-fits-all educational text messages, with patient monitoring and transmission of blood glucose values.
Dulce Digital-Me (Automated Delivery)
n=85 Participants
The second of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered via automated algorithm-driven messaging, incorporated into existing primary care team processes.
Dulce Digital-Me (Medical Assistants)
n=74 Participants
The third of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered by Medical Assistants, incorporated into existing primary care team processes.
Dulce Digital-Me (Combined: Automated Delivery and Medical Assistants)
n=159 Participants
Dulce Digital-Me (Combination of two intervention groups: Automated Delivery and Medical Assistants)
Participated in Flexibility Exercise; 6 Months From Enrollment
44 Participants
39 Participants
31 Participants
70 Participants

SECONDARY outcome

Timeframe: 12 months from baseline

Population: Participants

Participated in Flexibility Exercise as reported by patient; twelve months from enrollment

Outcome measures

Outcome measures
Measure
Dulce Digital
n=56 Participants
The first of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives one-size-fits-all educational text messages, with patient monitoring and transmission of blood glucose values.
Dulce Digital-Me (Automated Delivery)
n=63 Participants
The second of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered via automated algorithm-driven messaging, incorporated into existing primary care team processes.
Dulce Digital-Me (Medical Assistants)
n=51 Participants
The third of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered by Medical Assistants, incorporated into existing primary care team processes.
Dulce Digital-Me (Combined: Automated Delivery and Medical Assistants)
n=114 Participants
Dulce Digital-Me (Combination of two intervention groups: Automated Delivery and Medical Assistants)
Participated in Flexibility Exercise; 12 Months From Enrollment
29 Participants
34 Participants
15 Participants
49 Participants

SECONDARY outcome

Timeframe: 6 months from baseline

Population: Participants

Healthy Eating Behaviors as reported by patient; six months from enrollment The minimum score is 20 and the maximum score is 76. The higher score represents a better outcome.

Outcome measures

Outcome measures
Measure
Dulce Digital
n=89 Participants
The first of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives one-size-fits-all educational text messages, with patient monitoring and transmission of blood glucose values.
Dulce Digital-Me (Automated Delivery)
n=85 Participants
The second of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered via automated algorithm-driven messaging, incorporated into existing primary care team processes.
Dulce Digital-Me (Medical Assistants)
n=74 Participants
The third of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered by Medical Assistants, incorporated into existing primary care team processes.
Dulce Digital-Me (Combined: Automated Delivery and Medical Assistants)
n=159 Participants
Dulce Digital-Me (Combination of two intervention groups: Automated Delivery and Medical Assistants)
Healthy Eating Behaviors; 6 Months From Enrollment
50.12 score on a scale
Standard Deviation 6.38
50.48 score on a scale
Standard Deviation 6.96
49.41 score on a scale
Standard Deviation 6.66
49.98 score on a scale
Standard Deviation 6.82

SECONDARY outcome

Timeframe: 12 months from baseline

Population: Participants

Healthy Eating Behaviors as reported by patient; twelve months from enrollment The minimum score is 20 and the maximum score is 76. The higher score represents a better outcome.

Outcome measures

Outcome measures
Measure
Dulce Digital
n=56 Participants
The first of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives one-size-fits-all educational text messages, with patient monitoring and transmission of blood glucose values.
Dulce Digital-Me (Automated Delivery)
n=63 Participants
The second of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered via automated algorithm-driven messaging, incorporated into existing primary care team processes.
Dulce Digital-Me (Medical Assistants)
n=51 Participants
The third of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered by Medical Assistants, incorporated into existing primary care team processes.
Dulce Digital-Me (Combined: Automated Delivery and Medical Assistants)
n=114 Participants
Dulce Digital-Me (Combination of two intervention groups: Automated Delivery and Medical Assistants)
Healthy Eating Behaviors; 12 Months From Enrollment
51.04 score on a scale
Standard Deviation 6.0
50.24 score on a scale
Standard Deviation 5.81
50.67 score on a scale
Standard Deviation 6.19
50.43 score on a scale
Standard Deviation 5.96

SECONDARY outcome

Timeframe: 6 months from baseline

Population: Participants

Diabetes Distress as reported by patient; six months from enrollment The minimum score is 1 and the maximum score is 6. A higher score represents a worse outcome.

Outcome measures

Outcome measures
Measure
Dulce Digital
n=70 Participants
The first of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives one-size-fits-all educational text messages, with patient monitoring and transmission of blood glucose values.
Dulce Digital-Me (Automated Delivery)
n=65 Participants
The second of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered via automated algorithm-driven messaging, incorporated into existing primary care team processes.
Dulce Digital-Me (Medical Assistants)
n=62 Participants
The third of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered by Medical Assistants, incorporated into existing primary care team processes.
Dulce Digital-Me (Combined: Automated Delivery and Medical Assistants)
n=127 Participants
Dulce Digital-Me (Combination of two intervention groups: Automated Delivery and Medical Assistants)
Diabetes Distress; 6 Months From Enrollment
2.16 score on a scale
Standard Deviation 0.83
2.12 score on a scale
Standard Deviation 0.93
2.16 score on a scale
Standard Deviation 0.89
2.14 score on a scale
Standard Deviation 0.91

SECONDARY outcome

Timeframe: 12 months from baseline

Population: Participants

Diabetes Distress as reported by patient; twelve months from enrollment The minimum score is 1 and the maximum score is 6. A higher score represents a worse outcome.

Outcome measures

Outcome measures
Measure
Dulce Digital
n=53 Participants
The first of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives one-size-fits-all educational text messages, with patient monitoring and transmission of blood glucose values.
Dulce Digital-Me (Automated Delivery)
n=60 Participants
The second of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered via automated algorithm-driven messaging, incorporated into existing primary care team processes.
Dulce Digital-Me (Medical Assistants)
n=48 Participants
The third of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered by Medical Assistants, incorporated into existing primary care team processes.
Dulce Digital-Me (Combined: Automated Delivery and Medical Assistants)
n=108 Participants
Dulce Digital-Me (Combination of two intervention groups: Automated Delivery and Medical Assistants)
Diabetes Distress; 12 Months From Enrollment
1.96 score on a scale
Standard Deviation 0.75
2.23 score on a scale
Standard Deviation 0.96
2.07 score on a scale
Standard Deviation 0.94
2.16 score on a scale
Standard Deviation 0.95

SECONDARY outcome

Timeframe: 6 months from baseline

Population: Participants

Adherence to Refills and Medications Scale (ARMS) - Patient-reported Outcome; six months from enrollment The minimum score is 11 and the maximum score is 44. A higher score is a better outcome.

Outcome measures

Outcome measures
Measure
Dulce Digital
n=70 Participants
The first of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives one-size-fits-all educational text messages, with patient monitoring and transmission of blood glucose values.
Dulce Digital-Me (Automated Delivery)
n=64 Participants
The second of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered via automated algorithm-driven messaging, incorporated into existing primary care team processes.
Dulce Digital-Me (Medical Assistants)
n=62 Participants
The third of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered by Medical Assistants, incorporated into existing primary care team processes.
Dulce Digital-Me (Combined: Automated Delivery and Medical Assistants)
n=126 Participants
Dulce Digital-Me (Combination of two intervention groups: Automated Delivery and Medical Assistants)
Adherence to Refills and Medications Scale (ARMS) - Patient-reported Outcome; 6 Months From Enrollment
17.23 score on a scale
Standard Deviation 4.38
16.31 score on a scale
Standard Deviation 4.04
16.12 score on a scale
Standard Deviation 3.94
16.22 score on a scale
Standard Deviation 3.97

SECONDARY outcome

Timeframe: 12 months from baseline

Population: Participants

Adherence to Refills and Medications Scale (ARMS) - Patient-reported Outcome; twelve months from enrollment The minimum score is 11 and the maximum score is 44. A higher score is a better outcome.

Outcome measures

Outcome measures
Measure
Dulce Digital
n=53 Participants
The first of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives one-size-fits-all educational text messages, with patient monitoring and transmission of blood glucose values.
Dulce Digital-Me (Automated Delivery)
n=59 Participants
The second of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered via automated algorithm-driven messaging, incorporated into existing primary care team processes.
Dulce Digital-Me (Medical Assistants)
n=48 Participants
The third of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered by Medical Assistants, incorporated into existing primary care team processes.
Dulce Digital-Me (Combined: Automated Delivery and Medical Assistants)
n=107 Participants
Dulce Digital-Me (Combination of two intervention groups: Automated Delivery and Medical Assistants)
Adherence to Refills and Medications Scale (ARMS) - Patient-reported Outcome; 12 Months From Enrollment
16.68 score on a scale
Standard Deviation 4.23
16.25 score on a scale
Standard Deviation 4.26
15.85 score on a scale
Standard Deviation 3.88
16.08 score on a scale
Standard Deviation 4.08

Adverse Events

Dulce Digital

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Dulce Digital-Me (Automated Delivery)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Dulce Digital-Me (Medical Assistant)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 1 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Athena Philis-Tsimikas, MD, Co-Principal Investigator

Scripps Health

Phone: 858-678-7045

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place